NCT04385680View on ClinicalTrials.gov

Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

840

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

March 10, 2022

Study Completion Date

August 30, 2022

Conditions
Postpartum EndometritisWound InfectionChlorhexidine Adverse ReactionPostoperative Fever
Interventions
DRUG

Chlorhexidine Gluconate vaginal solution 0.05%

preoperative vaginal preparation

Trial Locations (1)

62411

Armed Forces Hospitals Southern Region, Khamis Mushait

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04385680 - Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis | Biotech Hunter | Biotech Hunter